Literature DB >> 8556485

Maternal antibodies and acquired serological response to Moraxella catarrhalis in children determined by an enzyme-linked immunosorbent assay.

T Ejlertsen1, E Thisted, P A Ostergaard, J Renneberg.   

Abstract

An enzyme-linked immunosorbent assay (ELISA) for determination of serum immunoglobulin G (IgG) antibodies to Moraxella catarrhalis was developed, with an ultrasonic extract of M. catarrhalis immobilized on polystyrene microtiter plates serving as the antigen. The specificity was determined by adsorption tests. All of the 541 women tested showed a high level of maternal IgG antibodies to M. catarrhalis in umbilical cord blood specimens. One hundred eighty-nine children aged 0 to 15 years were examined. A low level of IgG antibodies to M. catarrhalis in serum was found in children aged up to 1 year; in older children, the levels increased with age. Levels in the same range as maternal IgG antibody levels were reached at the age of 10 years. The level of antibodies in children did not correlate with the state of colonization with M. catarrhalis or with the state of acute lower respiratory tract infection. Pairs of acute-phase and convalescent-phase serum samples did not discriminate between the children with M. catarrhalis in pure culture and those with mixed cultures of M. catarrhalis, Haemophilus influenzae, and Streptococcus pneumoniae. In adult women, high IgG antibody levels and low colonization rates with M. catarrhalis were found, whereas in small children, low IgG antibody levels and high colonization rates were found.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8556485      PMCID: PMC368290          DOI: 10.1128/cdli.1.4.464-468.1994

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  27 in total

1.  The IgG subclass responses of human lymphocytes to B-cell activators.

Authors:  L Walker; G D Johnson; I C MacLennan
Journal:  Immunology       Date:  1983-10       Impact factor: 7.397

2.  Acute maxillary sinusitis in children.

Authors:  E R Wald; G J Milmoe; A Bowen; J Ledesma-Medina; N Salamon; C D Bluestone
Journal:  N Engl J Med       Date:  1981-03-26       Impact factor: 91.245

3.  Neonatal pneumonia caused by Branhamella catarrhalis.

Authors:  A Ohlsson; T Bailey
Journal:  Scand J Infect Dis       Date:  1985

4.  The effect of aging on human serum immunoglobulin concentrations.

Authors:  C E Buckley; F C Dorsey
Journal:  J Immunol       Date:  1970-10       Impact factor: 5.422

5.  Bronchopulmonary infection due to Branhamella catarrhalis: 11 cases assessed by transtracheal puncture.

Authors:  G Ninane; J Joly; M Kraytman
Journal:  Br Med J       Date:  1978-02-04

6.  Branhamella catarrhalis pneumonia and immunoglobulin abnormalities: a new association.

Authors:  L A Diamond; B Lorber
Journal:  Am Rev Respir Dis       Date:  1984-05

7.  Bacteremia caused by a beta-lactamase producing strain of Branhamella catarrhalis. A case report.

Authors:  J J Christensen; B Bruun
Journal:  Acta Pathol Microbiol Immunol Scand B       Date:  1985-08

8.  Acute otitis media caused by Branhamella catarrhalis: biology and therapy.

Authors:  G F Van Hare; P A Shurin; C D Marchant; N A Cartelli; C E Johnson; D Fulton; S Carlin; C H Kim
Journal:  Rev Infect Dis       Date:  1987 Jan-Feb

9.  A protein antigen characteristic of Branhamella catarrhalis. Serological identification of the genus.

Authors:  I Eliasson
Journal:  Acta Pathol Microbiol Scand B       Date:  1980-10

10.  Branhamella catarrhalis: significance in pulmonary infections and bacteriological features.

Authors:  J J Christensen; O Gadeberg; B Bruun
Journal:  Acta Pathol Microbiol Immunol Scand B       Date:  1986-04
View more
  5 in total

1.  Serum antibody response to outer membrane proteins of Moraxella (Branhamella) catarrhalis in patients with bronchopulmonary infection.

Authors:  J J Christensen; N Q Hansen; B Bruun
Journal:  Clin Diagn Lab Immunol       Date:  1996-11

2.  Comparison of the serological responses to Moraxella catarrhalis immunoglobulin D-binding outer membrane protein and the ubiquitous surface proteins A1 and A2.

Authors:  Thuan Tong Tan; Jens Jørgen Christensen; Morten Hanefeld Dziegiel; Arne Forsgren; Kristian Riesbeck
Journal:  Infect Immun       Date:  2006-09-11       Impact factor: 3.441

Review 3.  Moraxella catarrhalis: from emerging to established pathogen.

Authors:  Cees M Verduin; Cees Hol; André Fleer; Hans van Dijk; Alex van Belkum
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

4.  The levels and bactericidal capacity of antibodies directed against the UspA1 and UspA2 outer membrane proteins of Moraxella (Branhamella) catarrhalis in adults and children.

Authors:  D Chen; V Barniak; K R VanDerMeid; J C McMichael
Journal:  Infect Immun       Date:  1999-03       Impact factor: 3.441

Review 5.  Moraxella catarrhalis: clinical significance, antimicrobial susceptibility and BRO beta-lactamases.

Authors:  K McGregor; B J Chang; B J Mee; T V Riley
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-04       Impact factor: 3.267

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.